Mitochondrial transplantation attenuates lipopolysaccharide-induced acute respiratory distress syndrome

Seo-Eun Lee,In-Hyeon Kim,Young Cheol Kang,Yujin Kim,Shin-Hye Yu,Jeong Seon Yeo,Iksun Kwon,Jun Hyeok Lim,Je-Hein Kim,Kyuboem Han,Sung-Hwan Kim,Chun-Hyung Kim
DOI: https://doi.org/10.1186/s12890-024-03304-2
IF: 3.1
2024-09-28
BMC Pulmonary Medicine
Abstract:The mitochondria are essential organelles not only providing cellular energy in the form of ATP, but also regulating the inflammatory response and the cell death program. Mitochondrial dysfunction has been associated with various human diseases, including metabolic syndromes as well as inflammatory and neurodegenerative diseases. Acute respiratory distress syndrome (ARDS) is an acute pulmonary disorder characterized by uncontrolled alveolar inflammation, apoptotic lung epithelial/endothelial cells, and pulmonary edema. Despite the high mortality of ARDS, an effective pharmacotherapy to treat this disease has not been established yet. Therefore, identifying a novel targeted therapy for ARDS is important. Recently, exogenous mitochondrial transplantation was reported to be beneficial for treating mitochondrial dysfunction. The current study aimed to investigate the therapeutic effect of mitochondrial transplantation on ARDS in vitro and in vivo.
respiratory system
What problem does this paper attempt to address?